Lhasa Limited shared knowledge shared progress

2019 Pharmaceutical Industry and Regulators Symposium Recording - Day 1, Part 2

Teasdale A; Anax A;

This video is a recording of the second two presentations given at the 2019 Pharmaceutical Industry and Regulators Symposium in May 2019.

Presentation 1: Valsartan – Implications.
Dr. Andy Teasdale, AstraZeneca, Senior Principal Scientist

Presentation 2: In silico prediction of Mutagenicity.
Antonio Anax, Kimberly-Clark Corporation, Principal Toxicologist


Additional Documents

    © 2022 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
    VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

    Apart from the free survey software, we also have access to QuestionPro's free survey templates . We've found many of them useful and powerful to collect insights from various stakeholders of our organization.